Concourse Financial Group Securities’s Rubius Therapeutics, Inc RUBY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 10607 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 10887 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 10797 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 10644 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 10666 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 10795 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 10837 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 10915 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 10535 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 10538 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 10353 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 10136 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 9893 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 9450 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 8783 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 8277 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 7781 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 7317 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 7010 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 6806 |
|
|
2020
Q1 | – | Sell |
-73
| Closed | -$1K | – | 6687 |
|
|
2019
Q4 | $1K | Buy |
+73
| New | +$1K | ﹤0.01% | 2024 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 6437 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 6407 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 6265 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 6180 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 6017 |
|